XIV Eurasian Hematology-Oncology Congress - EHOC 2023
J

Case Discussion: R/R Follicular Lymphoma With Cutaneous Merkel Cell Carcinoma

By XIV Eurasian Hematology-Oncology Congress - EHOC 2023 FEATURING John Lister
By XIV Eurasian Hematology-Oncology Congress - EHOC 2023 FEATURING John Lister
0 views
February 21, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Recommended

AUTOPLAY
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

Feat. B. D. Cheson
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
06:33
Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

27:51
Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa
13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl
17:07
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their…

Feat. M. Minnema
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
18:24
Memorial Sloan Kettering Cancer Center

Key Lymphoma Updates From ASH

Feat. P. Torka
19:46
Scripps Health

Management of Indolent NHL

Feat. E. Brem
21:20
Dana-Farber Cancer Institute

Year in Review: Updates in Non-Melanoma Skin Cancers

Feat. K. Khaddour
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
08:28
Bruce D. Cheson

Tazemetostat in R/R FL: Impact of EZH2 Mutational Status on PFS

19:20
Mitchell Smith

Treatment Landscape in Follicular Lymphoma

25:23
Indy Hematology Review

When Not to Watch and Wait: Emerging Strategies in the Treatment of …

Feat. M. Williams
08:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Zanubrutinib + Obinutuzumab vs. Obinutuzu…

Feat. C. Flowers
19:14
SOHO Brazil 2024

FL: How Do I Deal With Relapse?

Feat. B. Kahl
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
22:38
Indy Hematology Review

Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…

Feat. T. Phillips
15:32
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Current Clinical Management of Follicular Lymphoma

Feat. B. Ferhanoğlu
14:34
Northwestern Medicine Oncology and Hematology

EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial

Feat. L. Gordon